CanSino Biologics Inc 6185-HK:Hong Kong Stock Exchange

*Data is delayed | HKD
Last | 4:08 PM CTT
346.20quote price arrow down-31.00 (-8.22%)
Volume
1,949,610
52 week range
71.60 - 450.00

...

Loading . . .

KEY STATS

  • Open378.40
  • Day High387.00
  • Day Low343.00
  • Prev Close377.20
  • 52 Week High450.00
  • 52 Week High Date02/11/21
  • 52 Week Low71.60
  • 52 Week Low Date03/13/20
  • Market Cap10,592.61M
  • Shares Out222.65M
  • 10 Day Average Volume2.43M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change316.61

RATIOS/PROFITABILITY

  • EPS (TTM)-0.94
  • P/E (TTM)-369.87
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest CanSino Biologics Inc News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
CanSino Biologics Inc is a clinical-stage vaccine company in China. The Company's products include Ad5-EBOV vaccine used for Ebola virus, MCV2 and MCV4 vaccines for meningococcus, PBPV vaccine used for pneumococcal and the recombinant novel coronavirus vaccine. Its products are mainly used in meningitis, diphtheria pertussis tetanus (DPT) and pneumonia.
Xuefeng Yu
Chairman
Shou Bai Chao
Chief Operating Officer
Jing Wang
Chief Financial Officer
Address
Tianjin, TNJ
300457
China